The Delayed-Start Study Design

被引:83
作者
D'Agostino, Ralph B., Sr. [1 ]
机构
[1] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA
关键词
DISEASE;
D O I
10.1056/NEJMsm0904209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1304 / 1306
页数:3
相关论文
共 7 条
[1]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[2]  
2-B
[3]  
Leber P, 1997, ALZ DIS ASSOC DIS, V11, pS10
[4]  
Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194
[5]   The evaluation of disease modifying therapies in Alzheimer's disease: a regulatory viewpoint [J].
Mani, RB .
STATISTICS IN MEDICINE, 2004, 23 (02) :305-314
[6]   A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease [J].
Olanow, C. Warren ;
Rascol, Olivier ;
Hauser, Robert ;
Feigin, Paul D. ;
Jankovic, Joseph ;
Lang, Anthony ;
Langston, William ;
Melamed, Eldad ;
Poewe, Werner ;
Stocchi, Fabrizio ;
Tolosa, Eduardo .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1268-1278
[7]  
Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561